“Lazarus Response” to Olaparib in a Virtually Chemonaive Breast Cancer Patient Carrying Gross BRCA2 Gene Deletion

This report describes an estrogen receptor-positive breast cancer patient, who relapsed at two and a half years after the completion of adjuvant chemotherapy while being on the aromatase inhibition. Based on the clinical evidence for potential sensitivity of the tumor to hormone ablation, everolimus...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Cureus
Hauptverfasser: Moiseyenko, Vladimir M, Chubenko, Vyacheslav A, Moiseyenko, Fedor V, Zagorskaya, Lyudmila A, Zaytseva, Yuliya A, Gesha, Nataliya E, Zykov, Evgeny N, Ni, Valeriya I, Preobrazhenskaya, Elena V, Sokolenko, Anna P, Imyanitov, Evgeny N
Format: Artigo
Sprache:Inglês
Veröffentlicht: Cureus 2018
Schlagworte:
Genetics
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5890964/
https://ncbi.nlm.nih.gov/pubmed/29651367
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7759/cureus.2150
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge